Physician profile
Wade Gobbell
NPI 1073040911
$29,478.85
in general payments reported to CMS, 2019-2025
29 companies · $2,616 in 2025
The $2,616 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $787 · 2021: $1,043 · 2022: $896 · 2023: $21K · 2024: $2,321 · 2025: $2,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $19K · Food and Beverage: $3,496 · Travel and Lodging: $3,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $19,000.00 |
| Food and Beverage | $3,495.66 |
| Travel and Lodging | $3,386.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,589.36 | 2023-2024 | |
| Stryker Corporation | $2,575.58 | 2019-2025 | Makoplasty, Mako, 1788 |
| Smoky Mountain Surgical LLC | $1,457.34 | 2023-2024 | |
| Medical Device Business Services, INC. | $1,413.90 | 2019-2023 | Attune |
| Smith+Nephew, INC. | $674.26 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System, Stravix, Aetos Shoulder System |
| Depuy Synthes Sales INC. | $531.71 | 2021-2023 | Attune, Na |
| Vericel Corporation | $272.53 | 2021-2025 | Maci |
| Zimmer Biomet Holdings, INC. | $272.51 | 2019-2021 | |
| Miach Orthopaedics, INC. | $256.08 | 2025 | |
| Polarityte, INC. | $215.93 | 2019-2020 | |
| Heraeus Medical, LLC. | $174.12 | 2019-2022 | |
| Kci USA, INC. | $139.20 | 2019-2021 | |
| Baxter Healthcare | $125.81 | 2022 | |
| Medacta USA, INC. | $100.19 | 2021 | |
| Next Science LLC | $96.97 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $87.58 | 2021 | |
| Linvatec Corporation | $82.75 | 2023 | Biobrace 23mm |
| Vertex Pharmaceuticals Incorporated | $73.79 | 2025 | |
| Ferring Pharmaceuticals INC. | $64.76 | 2024-2025 | Euflexxa |
| Nalu Medical, INC. | $57.49 | 2024 | Nalu Neurostimulation System |
| Encore Medical, Lp | $45.54 | 2024 | Djo Surgical |
| Orthalign INC | $34.23 | 2025 | Orthalign Plus |
| Pacira Therapeutics, INC. | $22.92 | 2021 | |
| Si-Bone, INC. | $22.87 | 2021 | |
| Bioventus LLC | $21.34 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $19.26 | 2023 | |
| Davol INC. | $17.36 | 2024 | |
| Kairos Surgical INC | $17.15 | 2023 | |
| Ibsa Pharma INC. | $16.32 | 2023 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Gobbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.